Pharmacology
820 articles · 39 journals
Journals in this subcategory (39)
- Biomedicine & Pharmacotherapy · Elsevier (90)
- Drug and Alcohol Dependence · Elsevier (88)
- Fitoterapia · Elsevier (85)
- Progress in Neuro-Psychopharmacology & Biological Psychiatry · Elsevier (80)
- Neuropsychopharmacology · Elsevier (68)
- Neurotherapeutics · Elsevier (58)
- Steroids · Elsevier (47)
- Drug Resistance Updates · Elsevier (45)
- The Journal of Pharmacology and Experimental Therapeutics · Elsevier (43)
- Intelligent Pharmacy · Elsevier (34)
- Drug Metabolism and Disposition · Elsevier (32)
- Current Radiopharmaceuticals · Elsevier (31)
- European Neuropsychopharmacology · Elsevier (27)
- Pharmacological Reviews · Elsevier (27)
- Prostaglandins & Other Lipid Mediators · Elsevier (16)
- Molecular Pharmacology · Elsevier (14)
- Medicine in Drug Discovery · Elsevier (11)
- Acta Pharmacologica Sinica · Springer Nature (8)
- Nature Reviews Drug Discovery · Springer Nature (8)
- Neuropsychopharmacology · Springer Nature (8)
- Apoptosis · Springer Nature (0)
- BMC Pharmacology and Toxicology · Springer Nature (0)
- BioDrugs · Springer Nature (0)
- Cardiovascular Drugs and Therapy · Springer Nature (0)
- Current Cardiovascular Risk Reports · Springer Nature (0)
- Current Pharmacology Reports · Springer Nature (0)
- DARU Journal of Pharmaceutical Sciences · Springer Nature (0)
- Drug Safety · Springer Nature (0)
- European Journal of Clinical Pharmacology · Springer Nature (0)
- European Journal of Drug Metabolism and Pharmacokinetics · Springer Nature (0)
- Future Journal of Pharmaceutical Sciences · Springer Nature (0)
- Inflammation Research · Springer Nature (0)
- Journal of Pharmacokinetics and Pharmacodynamics · Springer Nature (0)
- Naunyn-Schmiedeberg's Archives of Pharmacology · Springer Nature (0)
- Pharmaceutical Research · Springer Nature (0)
- PharmacoEconomics - Open · Springer Nature (0)
- Pharmacological Reports · Springer Nature (0)
- Psychopharmacology · Springer Nature (0)
- Saudi Pharmaceutical Journal · Springer Nature (0)
- OSU-03012 mitigates pulmonary fibrosis by targeting ECM proteins via suppression of S6K-mediated translation and acceleration of MMP-driven clearance
- Acteoside alleviates Parkinson’s disease-associated neurodegeneration and oxidative stress via an m6A-dependent Nrf2 regulatory axis
- LASSBio-753 as a new prototype of anti-tumor necrosis factor-alpha anti-inflammatory drug
- The anti-GPC1 antibody AT101 as effective targeting agent for chemotherapeutic-loaded chitosan nanobubbles in the treatment of pancreatic adenocarcinoma
- Artificial intelligence in basic and translational cardiovascular research
- Survexins and SurvexANs – novel nano-encapsulated inhibitors of Crm1-dependent nuclear export of Survivin
- Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors selectively induce cell death in human glioblastoma stem cells: Perspectives for preventing glioblastoma recurrence
- Conessine, a steroidal alkaloid from Holarrhena antidysenterica: Ethnomedical roots, pharmacological insights, and formulation strategies for modern drug development
- Exploration of steroidal alkaloids: Integrating pharmacognosy, chemoinformatics and artificial intelligence for application diversification
- Retraction notice to “Effective synthesis of a hexacycl-steroid derivative from 4-hydroxyestrone” [Steroids 163 (2020) 108715]
- Retraction notice to “Design and synthesis of two new steroid derivatives with biological activity on heart failure via the M2-muscarinic receptor activation” [Steroids 158 (2020) 108620]
- Retraction notice to "Melatonin protects chondrocytes from impairment induced by glucocorticoids via NAD+-dependent SIRT1" [Steroids 126 (2017) 24–29]
- Machine learning–based source-level EEG functional network biomarkers of antidepressant treatment response in major depressive disorder
- Single-dose methamphetamine alters object recognition performance under pre-training and pre-retrieval conditions and is associated with dentate gyrus TrkB signaling changes in mice
- Clinical instability, inflammatory markers, and mortality in schizophrenia spectrum disorders: A large real-world cohort study
- Mesocorticolimbic reactivity to a newly conditioned visual signal for alcohol ingestion in the human laboratory and its behavioral correlates
- Doxycycline attenuates anxiety-like behavior and social deficits during alcohol withdrawal in zebrafish: potential involvement of matrix metalloproteinases
- Targeting GPR3 as a novel approach for nicotine cessation therapeutic development
- Concerted elevations of cortical and striatal glutamate and GABA in antipsychotic-free individuals at clinical high-risk for psychosis
- Optimizing social media initiatives to promote Neuropsychopharmacology (NPP) publications
- In Memoriam: Terry A. Ketter, MD
- The path to treating multiple-etiology dementia: Combining vascular risk control and disease-modifying neurodegenerative therapies
- New approach methodologies in neurotherapeutics development
- GPCR heteromers: Beyond the monomeric paradigm in neuropsychiatric drug discovery
- Immunosenescence as a modifiable driver of neurodegenerative diseases: Pathways and multidimensional emerging strategies for Alzheimer's and Parkinson's diseases
- Targeting prostaglandin catabolism via topical nanotherapy rescues vision in ischemic optic neuropathy
- In Memoriam Peter Charles Whybrow, M.D., D.P.M., M.B., F.R.C.P
- Triazole-based structural modification of plant- and fungal-derived natural products: recent advances in bioactivity and medicinal potential
- Cordyceps proteins: An uncharted frontier in therapeutic bioactive research
- Bioactive compounds and therapeutic potential of the Brazilian genus Kielmeyera (Calophyllaceae): a comprehensive review